Scheifele M, Gnorich J, Schroder E, Kunte S, Ells Z, Hagen J
Eur J Nucl Med Mol Imaging. 2025; .
PMID: 40064709
DOI: 10.1007/s00259-025-07188-0.
Schalbroeck R, van Hooijdonk C, Bos D, Booij J, Selten J
Mol Psychiatry. 2024; 29(12):3841-3856.
PMID: 38760501
DOI: 10.1038/s41380-024-02581-x.
Grochecki P, Smaga I, Surowka P, Marszalek-Grabska M, Kalaba P, Dragacevic V
Int J Mol Sci. 2022; 23(18).
PMID: 36142621
PMC: 9503873.
DOI: 10.3390/ijms231810718.
Sonti S, Tyagi K, Pande A, Daniel R, Sharma A, Tyagi M
Vaccines (Basel). 2022; 10(2).
PMID: 35214661
PMC: 8875185.
DOI: 10.3390/vaccines10020202.
Lehnert W, Riss P, Hurtado de Mendoza A, Lopez S, Fernandez G, Ilheu M
EJNMMI Res. 2022; 12(1):1.
PMID: 35006412
PMC: 8748605.
DOI: 10.1186/s13550-021-00873-9.
DAT1 Gene Methylation as an Epigenetic Biomarker in Attention Deficit Hyperactivity Disorder: A Commentary.
Tonelli E, Pascale E, Troianiello M, DAddario C, Adriani W
Front Genet. 2020; 11:444.
PMID: 32477403
PMC: 7232962.
DOI: 10.3389/fgene.2020.00444.
Is dopamine transporter-mediated dopaminergic signaling in the retina a noninvasive biomarker for attention-deficit/ hyperactivity disorder? A study in a novel dopamine transporter variant Val559 transgenic mouse model.
Dai H, Jackson C, Davis G, Blakely R, McMahon D
J Neurodev Disord. 2017; 9(1):38.
PMID: 29281965
PMC: 5745861.
DOI: 10.1186/s11689-017-9215-8.
Evaluation of VNTR polymorphisms of dopamine transporter gene and the risk of bipolar disorder in Zahedan, southeast Iran.
Shakiba M, Hashemi M, Mahdar S, Rahbari Z, Bahari G
Mol Biol Res Commun. 2017; 6(3):123-127.
PMID: 29071281
PMC: 5640894.
DOI: 10.22099/mbrc.2017.25056.1261.
Potential for diagnosis versus therapy monitoring of attention deficit hyperactivity disorder: a new epigenetic biomarker interacting with both genotype and auto-immunity.
Adriani W, Romano E, Pucci M, Pascale E, Cerniglia L, Cimino S
Eur Child Adolesc Psychiatry. 2017; 27(2):241-252.
PMID: 28822049
DOI: 10.1007/s00787-017-1040-9.
Striatal and Extrastriatal Dopamine Transporter Availability in Schizophrenia and Its Clinical Correlates: A Voxel-Based and High-Resolution PET Study.
Artiges E, Leroy C, Dubol M, Prat M, Pepin A, Mabondo A
Schizophr Bull. 2017; 43(5):1134-1142.
PMID: 28177089
PMC: 5581903.
DOI: 10.1093/schbul/sbw192.
Using iPSC-derived human DA neurons from opioid-dependent subjects to study dopamine dynamics.
Sheng Y, Filichia E, Shick E, Preston K, Phillips K, Cooperman L
Brain Behav. 2016; 6(8):e00491.
PMID: 27547496
PMC: 4884574.
DOI: 10.1002/brb3.491.
CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
Tristao F, Lazzarini M, Martin S, Amar M, Stuhmer W, Kirchhoff F
Neurotox Res. 2015; 29(3):364-80.
PMID: 26403659
DOI: 10.1007/s12640-015-9557-5.
The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants.
Mergy M, Gowrishankar R, Gresch P, Gantz S, Williams J, Davis G
Proc Natl Acad Sci U S A. 2014; 111(44):E4779-88.
PMID: 25331903
PMC: 4226116.
DOI: 10.1073/pnas.1417294111.
Challenges and recent advances in mass spectrometric imaging of neurotransmitters.
Gemperline E, Chen B, Li L
Bioanalysis. 2014; 6(4):525-40.
PMID: 24568355
PMC: 4159677.
DOI: 10.4155/bio.13.341.
Prenatal stress induces increased striatal dopamine transporter binding in adult nonhuman primates.
Converse A, Moore C, Moirano J, Ahlers E, Larson J, Engle J
Biol Psychiatry. 2013; 74(7):502-10.
PMID: 23726316
PMC: 3775901.
DOI: 10.1016/j.biopsych.2013.04.023.
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling.
Bowes J, Brown A, Hamon J, Jarolimek W, Sridhar A, Waldron G
Nat Rev Drug Discov. 2012; 11(12):909-22.
PMID: 23197038
DOI: 10.1038/nrd3845.
Immunization with DAT fragments is associated with long-term striatal impairment, hyperactivity and reduced cognitive flexibility in mice.
Adriani W, Koot S, Columba-Cabezas S, Romano E, Travaglini D, van den Bos R
Behav Brain Funct. 2012; 8:54.
PMID: 23192105
PMC: 3537576.
DOI: 10.1186/1744-9081-8-54.
Association between polymorphisms of the DBH and DAT1 genes and attention deficit hyperactivity disorder in children from Jordan.
Gharaibeh M, Batayneh S, Khabour O, Daoud A
Exp Ther Med. 2012; 1(4):701-705.
PMID: 22993592
PMC: 3445892.
DOI: 10.3892/etm_00000108.
Dopamine-mediated autocrine inhibitory circuit regulating human insulin secretion in vitro.
Simpson N, Maffei A, Freeby M, Burroughs S, Freyberg Z, Javitch J
Mol Endocrinol. 2012; 26(10):1757-72.
PMID: 22915827
PMC: 3458225.
DOI: 10.1210/me.2012-1101.
Lmx1a regulates dopamine transporter gene expression during ES cell differentiation and mouse embryonic development.
Chung S, Kim C, Kim K
J Neurochem. 2012; 122(2):244-50.
PMID: 22564125
PMC: 3421045.
DOI: 10.1111/j.1471-4159.2012.07779.x.
